Alvogen

Setting a new standard for the future of pharma 

DNA glass 2
Company

Who we are 

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the counter (OTC) and biosimilar products for patients around the world. With commercial footprint in over 35 markets, Alvogen’s key regions include the U.S. and emerging markets in the CEE and APAC regions.

hands
Products

Targeted portfolio 

Alvogen's product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, in addition to a fast-growing portfolio of biosimilars, brands and OTC products.

Serbia
Purpose

Making people´s lives better 

Our true purpose as a company is to make people's lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise be able to afford them.

Robert Wessman Staircase@2x
Leadership team

Meet our CEO 

Robert Wessman‘s business plan for Alvogen was originally scribbled on a napkin in a New York restaurant back in 2009 in the middle of one of the worst financial crises in history when access to capital was virtually non-existent.

Worldwide

Worldwide offices 

Alvogen has commercial operations in 35 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and Romania.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.